The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells (Q40131236)
Jump to navigation
Jump to search
scientific article published on May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells |
scientific article published on May 2007 |
Statements
1 reference
The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells (English)
1 reference
Sagar Lonial
1 reference
Fadlo R Khuri
1 reference
Xiangguo Liu
1 reference
Ping Yue
1 reference
Shuzhen Chen
1 reference
Liping Hu
1 reference
Shi-Yong Sun
1 reference
1 May 2007
1 reference
1 reference
Identifiers
1 reference